Literature DB >> 21867860

Intranasal fentanyl for pain management in children: a systematic review of the literature.

Shawna Mudd1.   

Abstract

Intranasally administered fentanyl (INF) has been studied as an alternate route of delivery for pain relief in children. The purpose of this systematic review is to evaluate the available research evidence on the use of INF in the pediatric population. A search was conducted of PubMed, ISI, Scopus, Popline, CINAHL, and Embase for research studies evaluating INF in this population (0-18 years of age). The studies were graded on the strength of the evidence and the results reviewed. All of the reviewed studies showed similar or improved pain scores when compared with other opioids and administration methods. No severe adverse outcomes were reported. Current evidence suggests that INF is a safe and effective method of pain management for children in a variety of clinical settings.
Copyright © 2011 National Association of Pediatric Nurse Practitioners. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21867860     DOI: 10.1016/j.pedhc.2010.04.011

Source DB:  PubMed          Journal:  J Pediatr Health Care        ISSN: 0891-5245            Impact factor:   1.812


  16 in total

1.  Treating and Reducing Anxiety and Pain in the Paediatric Emergency Department: The TRAPPED survey.

Authors:  Evelyne D Trottier; Samina Ali; Sylvie Le May; Jocelyn Gravel
Journal:  Paediatr Child Health       Date:  2015 Jun-Jul       Impact factor: 2.253

Review 2.  Managing pain and distress in children undergoing brief diagnostic and therapeutic procedures.

Authors:  Evelyne D Trottier; Marie-Joëlle Doré-Bergeron; Laurel Chauvin-Kimoff; Krista Baerg; Samina Ali
Journal:  Paediatr Child Health       Date:  2019-12-09       Impact factor: 2.253

3.  Correction to: Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.

Authors:  Victoria C Ziesenitz; Janelle D Vaughns; Gilbert Koch; Gerd Mikus; Johannes N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

Review 4.  [Nalbuphine in pediatric anesthesia].

Authors:  A-M Schultz-Machata; K Becke; M Weiss
Journal:  Anaesthesist       Date:  2014-02       Impact factor: 1.041

5.  Nasal delivery of fentanyl.

Authors:  Peter Watts; Alan Smith; Michael Perelman
Journal:  Drug Deliv Transl Res       Date:  2013-02       Impact factor: 4.617

Review 6.  Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.

Authors:  Victoria C Ziesenitz; Janelle D Vaughns; Gilbert Koch; Gerd Mikus; Johannes N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-02       Impact factor: 6.447

7.  Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain.

Authors:  Sebastiano Mercadante; Renato Vellucci; Arturo Cuomo; Claudio Adile; Andrea Cortegiani; Alessandro Valle; Patrizia Villari; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2014-10-29       Impact factor: 3.603

Review 8.  Managing Pediatric Pain in the Emergency Department.

Authors:  Benoit Bailey; Evelyne D Trottier
Journal:  Paediatr Drugs       Date:  2016-08       Impact factor: 3.022

Review 9.  Intranasal fentanyl for the management of acute pain in children.

Authors:  Adrian Murphy; Ronan O'Sullivan; Abel Wakai; Timothy S Grant; Michael J Barrett; John Cronin; Siobhan C McCoy; Jeffrey Hom; Nandini Kandamany
Journal:  Cochrane Database Syst Rev       Date:  2014-10-10

10.  Treating and reducing anxiety and pain in the paediatric emergency department-TIME FOR ACTION-the TRAPPED quality improvement collaborative.

Authors:  Evelyne D Trottier; Samina Ali; Jennifer Thull-Freedman; Garth Meckler; Antonia Stang; Robert Porter; Mathieu Blanchet; Alexander Sasha Dubrovsky; April Kam; Raagini Jain; Tania Principi; Gary Joubert; Sylvie Le May; Melissa Chan; Gina Neto; Maryse Lagacé; Jocelyn Gravel
Journal:  Paediatr Child Health       Date:  2018-02-05       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.